1.
RARE-12TOXICITY AND RESPONSE IN PATIENTS TREATED ACCORDING TO THE DUTCH SOCIETY FOR NEURO-ONCOLOGY (LWNO) MEDULLOBLASTOMA TREATMENT PROTOCOL WITH NEOADJUVANT CHEMOTHERAPY, RADIATIO...
2.
3.
Prognostic value and kinetics of circulating endothelial cells in patients with recurrent glioblastoma randomised to bevacizumab plus lomustine, bevacizumab single agent or lomusti...
4.
5.